Trials / Completed
CompletedNCT04940559
Study of Different Forms of Danicopan (Tablet, Softgel Capsule, Liquid-filled Capsule) in Healthy Participants
A Phase 1 Study To Determine The Relative Bioavailability Of ACH-0144471 After Administration Of A Tablet Or Softgel Capsule Versus A Liquid Filled Capsule In Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- Alexion Pharmaceuticals, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This was a randomized, crossover, open-label study to assess the relative bioavailability, pharmacokinetics (PK), and safety of three different formulations of danicopan (tablet, softgel capsule, liquid-filled capsule \[LFC\]) in healthy participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Danicopan - Tablet | Oral tablet. |
| DRUG | Danicopan - Softgel | Oral softgel capsule. |
| DRUG | Danicopan - LFC | Oral LFC. |
Timeline
- Start date
- 2016-08-02
- Primary completion
- 2016-10-05
- Completion
- 2016-10-05
- First posted
- 2021-06-25
- Last updated
- 2021-06-25
Locations
1 site across 1 country: New Zealand
Source: ClinicalTrials.gov record NCT04940559. Inclusion in this directory is not an endorsement.